MANUFACTURING TECHNOLOGY

HWAFUNE Breaks Through Textile Difficulties with Porlite by Creating New Trends in Functional Fabrics

HWAFUNE | June 28, 2022

HWAFUNE Breaks news
When mentioning Taiwan's traditional manufacturing, what pops into your head may be the textile industry. As a global hub for textile manufacturing, Taiwan has undergone significant changes over the past 30 years. Two of the most important changes are the relocation of industries to China and the government's New Southbound Policy.
While Taiwanese textile manufacturers' decision to relocate is mainly driven by the need to reduce costs using cheap overseas labor, the rising labor costs in Southeast Asia have forced the manufacturers to constantly move their production to other regions, turning them into textile industry nomads.

Despite these two relocation trends, HWAFUNE Textile which specializes in manufacturing functional fabrics has insisted on keeping production in Taiwan to provide reliable, high-quality products for esteemed customers. Instead of blindly pursing low costs and low prices through contract manufacturing and ending up in the red ocean, HWAFUNE Textile has strengthened the foothold of the Taiwanese textile industry in the global luxury market.

One of the hot topics in the functional apparel market in recent years is the European Union's ban on fabrics containing PTFE. Currently, membranes made of PU, TPU, and PTFE account for the majority of functional apparels. With superior moisture permeability and breathability, PTFE has been adopted more widely than the other two materials.

However, when heated to high temperatures during the manufacturing process, PTFE will generate PFOA which is classified as a possible human carcinogen. In addition, greenhouse gas is produced when fabrics containing this material are incinerated. Even if the fabrics are buried in landfills, PFOA will not decompose and will be washed into the ocean by rain. It then gets into the atmosphere via evaporation and is transported to everywhere by airflow or rain. PFOA has even been found in polar bears' livers.

Considering the potential impact of the EU's ban on the clothing market and consumers' fear of toxic substances, upmarket brands have been looking for alternative functional fabrics. Therefore, HWAFUNE has joined hands with Phoenix Innovative Materials to develop the functional fabric brand Porlite, which has rapidly won the heart of high-end functional apparel brands.

"In Light of Future Trends, HWAFUNE Develops Porlite Fabrics with Phoenix Innovative Materials  to take interest in PP membranes five years ago. Although HWAFUNE has the ability to mass produce fabrics featuring PTFE, PU, and TPU membranes, he believes PP membranes will become a trend in the functional apparel industry since the lifecycle of the material, from the production of the membrane and the manufacturing of the fabrics to the disposal of the clothing, is more in line with increased environmental awareness, I can guarantee that Porlite is capable of replacing existing functional fabrics and can fully address high-end brands' product development requirements"

-Jackson Chang,Chairman HWAFUNE.
Turning the ambitious vision into reality is not easy. In the past three years, these two companies worked closely on the manufacturing, testing, and modification of the membrane. Besides functionality, HWAFUNE also considered the needs of consumers during testing, such as waterproof, moisture permeability, and even the appearances of the fabrics after washing.

The reason that Chairman Chang is so committed is because he has put himself in consumers' shoes in the first place. He thinks environmental protection, safety, non-toxicity, and practicability should be combined perfectly. Product developers should not need to choose between them, nor should they force consumers to compromise on environmental protection, price, or quality.

Dr. Chang, who is responsible for technology development at Phoenix Innovative Materials, explains the three major advantages of Porlite which is produced through non-toxic manufacturing processes in Taiwan. Firstly, there are 10 billion pores arranged in an orderly manner on the membrane. As the pores are smaller than water molecules and bigger than air molecules, the fabric can resist water penetration, even under pressure, while maintaining breathability.

Moreover, since most outdoor exercises are relatively intense and will create a lot of sweat during the process, Porlite can also transport moisture from the clothing to the atmosphere by diffusion through the membrane, thus providing moisture permeability and breathability that no other functional apparel on market can achieve.

Porlite Captures Top Brands' Heart with Non-Toxic Manufacturing, Sustainability, Fastness to Washing, and Moisture Permeability
In line with the HWAFUNE's commitment to sustainability, the Durable Water Repellent (DWR) for Porlite can endure at least 30 laundering cycles and rain-resistant for period of time, thus providing a longer life span.

Manufacturing in Taiwan is one of the main reasons that Porlite has won favor with Europe-based tier-one sportswear brands. The high quality enables Porlite to stand out from other competitors and meet customers' needs for upscale and reliable products.

Both the PP membrane developed by Phoenix Innovative Materials and the Porlite fabric created by HWAFUNE are manufactured in Taiwan. Thanks to their insistence on domestic production, the companies have established a high-tech brand image for Taiwanese textile companies widely recognized by overseas esteemed customers. These are valuable experiences for both Phoenix Innovative Materials and HWAFUNE.

Instead of pursuing short-term profits through contract manufacturing services, Chairman Chang and Dr. Chang spent five years developing the Porlite fabric whose overwhelming advantages for environmental protection and functionality have spoken for itself. The goal is to establish bio-based manufacturing processes by using natural materials such as weeds as raw materials and to provide biodegradable products in 10 years.

Spotlight

Remanufacturing worn-out vehicle components are increasingly important. Around the world, ZF plants like Nottingham in the UK are putting a wide variety of used parts through an industrial remanufacturing process, saving energy and conserving valuable raw materials.


Other News
INNOVATION

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific

Cambrex | June 02, 2022

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced the acquisition of Q1 Scientific – a leading provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located in Waterford, Ireland. Stability storage and testing is a critical component of drug development and commercialization of new therapies. Q1 Scientific brings world-class capabilities to our ever-expanding portfolio of outsourced pharmaceutical services. This acquisition is a natural extension of our current offerings that will broaden and increase our expertise in this critical area, as well as our footprint in the European market." Tom Loewald, CEO, Cambrex. Q1 Scientific's state-of-the-art cGMP facility is ICH validated to meet the specific storage requirements of any pharmaceutical project, with options from -80 C storage up to +50 C, with a full range of humidity control. The 20,000 sq. ft. Waterford facility boasts nearly 40 walk-in stability storage chambers, reach-in freezers and stability units, and ultra-low temperature freezers for biologic therapies. The company also provides sample management and transport services. We're pleased to join Cambrex as we continue to provide leading stability storage services to our current customers, With Cambrex's scientific expertise and scale, we'll be able to accelerate our growth and offer an integrated suite of analytical services, providing a full range of market-leading solutions for our customers." Stephen Delaney, CEO, Q1 Scientific. Cambrex offers a variety of storage and testing capabilities with walk-in and reach-in chambers that meet the ICH Q1A requirements. The acquisition will expand Cambrex's capabilities into the European market. As pharmaceutical and biopharmaceutical companies continue to seek outsourcing options for non-core capabilities to reduce their footprint, Q1 Scientific's stability storage services, combined with Cambrex's industry-leading analytical services portfolio, provide specialized capabilities of high value to the industry. About Cambrex Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,200 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments. About Q1 Scientific Q1 Scientific was founded in Waterford, Ireland in 2013 by Louise Grubb, and offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries at their 20,000 sq ft. cGMP facility. As the first company in the sector to establish in Ireland, Q1 Scientific is revolutionizing the way pharmaceutical companies store their products, helping to improve the speed it takes for new drugs to reach the marketplace along with saving companies the expense of building and monitoring their own storage chambers.

Read More

INDUSTRIAL 4.0

Flyability releases the Elios 3, an indoor LiDAR drone for Industry 4.0

Flyability | May 23, 2022

Flyability unveils the Elios 3, the world's first collision-tolerant drone equipped with a LiDAR sensor for indoor 3D mapping. The drone is powered by a new SLAM engine called FlyAware™ that lets it create 3D models as it flies and accompanied by a new version of Flyability's software for inspectors, Inspector 4.0. Flyability pioneered confined space inspection drones with its first product in 2016. With the launch of the Elios 3, it continues its pledge to create cutting edge technology designed to keep humans out of dangerous places to perform the most demanding inspection tasks. The Elios 3 was made to address the need companies have for reliable inspection tools. As industries around the world scale up their use of drones, they need technology that is easy to use, performs the same way every time, and remains stable when working inside highly sensitive assets. "The Elios 3 has some of the very best stabilization in the world, a modular payload, the ability to create 3D models in real time while in flight, and it paves the way towards an increasingly autonomous future, For industrial inspections, the Elios 3 is a key enabler of Industry 4.0, presenting an inspection solution that can make inspections safer, more efficient, and less expensive than ever before." Patrick Thévoz, co-founder and CEO of Flyability The Elios 3 comes with an Ouster OS0-32 LiDAR sensor, allowing inspectors to collect data for the creation of survey-grade 3D models using software from Flyability's new partner, GeoSLAM. Mapping areas that are out of reach or too dangerous for humans is very difficult, yet critical to support operational decisions in many industries. By combining the best of confined space drone data capture and 3D geospatial software technology, Flyability's partnership with GeoSLAM enables professionals to produce survey-grade point clouds of the most inaccessible places in their workplace, completely removing the strain of approximations and guesswork from their operations. In addition to carrying a LiDAR sensor, the Elios 3 can accommodate a second payload that allows it to be customized for each individual user's needs. The Elios 3 is powered by Flyability's new proprietary SLAM engine FlyAware™, allowing it to turn the drone's LiDAR data into 3D models in real time, while the drone is in flight. FlyAware™ also gives the Elios 3 groundbreaking stability, combining data from the drone's three optical cameras and its LiDAR sensor to catch the tiniest unpredictable movement and instruct the flight controller to compensate for it. This stability and other ease-of-use features make the Elios 3 incredibly easy to operate, so that new pilots can be trained and perform their first inspection in the same day. Using Flyability's new Inspector 4.0 software made for reporting with the Elios 3, inspectors can now visualize Points of Interest found during an inspection in a high-resolution 3D map using Inspector 4.0's 3D Map Viewer. This feature lets stakeholders navigate from POI to POI in a digital representation of their assets, providing a clear visualization of the defects found within them to support planning, monitoring, and maintenance efforts. "The Elios 3 is the single biggest project that Flyability has ever undertaken," said Adrien Briod, CTO of Flyability. "If you think of the Elios 2 as your classic flip phone, only designed to make phone calls, the Elios 3 is the smartphone. It's made to be customized for the specific demands of each user, letting you attach the payload you need so you can use the tool as you like, and allowing it to grow and improve over time with new payloads or software solutions." Flyability has been working on the Elios 3 for four years. In that time, its engineers have spent thousands of hours on research and development and performed over 200 missions in the field to collect feedback, learn what clients want, and refine the technology in order to make the most reliable indoor drone on the market. As part of the effort to make the Elios 3, Flyability collaborated with top universities around the world by joining Team Cerberus, which competed in and won DARPA's multi-year Sub-T challenge for autonomous robotics in underground environments. About Flyability Flyability pioneered confined space inspection drones, creating new technology that allows inspectors to collect data remotely inside dangerous confined spaces instead of in person. Since launching in 2014, Flyability has become a trusted provider of internal inspection solutions, enabling remote data collection with cutting edge hardware and software for inspection professionals to help them improve safety, reduce downtimes, and cut costs for their internal inspections. Today Flyability has offices in Switzerland, China, Singapore, and the U.S., with almost one thousand clients in over 60 countries. Flyability works in every industry that requires internal inspections, including Power Generation, Oil & Gas, Mining, Wastewater Infrastructure, Chemicals, Maritime, and Infrastructure & Utilities.

Read More

MANUFACTURING TECHNOLOGY

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics | June 06, 2022

WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes (PFS), including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The maximum filling speed can reach 400 PFS/min to support 17 million syringes of drug products manufacturing every year. The increased manufacturing capacity at DP5 allows WuXi Biologics to provide global partners with faster and more robust end-to-end drug product services for their innovative products at different scales and stages. Compared to a traditional drug product filling line, DP5's state-of-the-art design and layout, single-use technology and automated equipment, significantly decrease the risk of contamination and maintain aseptic control required in the filling process. This process supports clients' products scale up to commercial capability and reliably delivers to patients under the highest quality standards which WuXi Biologics represents. Dr. Chris Chen, CEO of WuXi Biologics, commented, "Pre-filled syringes have emerged as one of the fastest-growing choices for biologics dosage form as our partners seek new and more convenient biologics delivery methods. The GMP operation of DP5, our first commercial drug product facility for pre-filled syringes, not only demonstrates our commitment to global partners, but also marks an important milestone for WuXi Biologics to become one of the global leaders in drug product CDMO services. We'll continue to enable our clients to advance innovative biologics towards clinical trials, regulatory approvals, and commercialization to benefit patients worldwide." About WuXi Biologics WuXi Biologics (2269.HK) is a global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop, and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide. With over 10,000 skilled employees in China, the United States, Ireland, Germany, and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development, and manufacturing solutions. As of the end of 2021, WuXi Biologics is supporting over 480 integrated client projects, including nine in commercial manufacturing. WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, further enhancing our commitment to sustainability.

Read More

MANUFACTURING TECHNOLOGY

Siemens and NVIDIA to Enable Industrial Metaverse

Siemens | June 30, 2022

Siemens, a leader in industrial automation and software, infrastructure, building technology and transportation, and NVIDIA, a pioneer in accelerated graphics and artificial intelligence (AI), today announced an expansion of their partnership to enable the industrial metaverse and increase use of AI-driven digital twin technology that will help bring industrial automation to a new level. As a first step in this collaboration, the companies plan to connect Siemens Xcelerator, the open digital business platform, and NVIDIA Omniverse™, a platform for 3D design and collaboration. This will enable an industrial metaverse with physics-based digital models from Siemens and real-time AI from NVIDIA in which companies make decisions faster and with increased confidence. The addition of Omniverse to the open Siemens Xcelerator partner ecosystem will accelerate the use of digital twins that can deliver productivity and process improvements across the production and product lifecycles. Companies of all sizes will be able to employ digital twins with real-time performance data; create innovative industrial IoT solutions; leverage actionable insights from analytics at the edge or in the cloud; and tackle the engineering challenges of tomorrow by making visually rich, immersive simulations more accessible. “Photorealistic, physics-based digital twins embedded in the industrial metaverse offer enormous potential to transform our economies and industries by providing a virtual world where people can interact and collaborate to solve real-world problems. Through this partnership, we will make the industrial metaverse a reality for companies of all sizes, For over a decade, our digital twin technology has been helping customers across all industries to boost their productivity and today offer the industry’s most comprehensive digital twin. When Siemens Xcelerator is connected to Omniverse, we will enable a real-time, immersive metaverse that connects hardware and software, from the edge to the cloud with rich data from Siemens’ software and solutions.” -Roland Busch, President and Chief Executive Officer, Siemens AG. Siemens and NVIDIA share a common vision that the industrial metaverse will drive digital transformation. This is just the first step in our joint effort to make this vision real for our customers and all parts of the global manufacturing industry, said Jensen Huang, founder and CEO, NVIDIA. The connection to Siemens Xcelerator will open NVIDIA’s Omniverse and AI ecosystem to a whole new world of industrial automation that is built using Siemens’ mechanical, electrical, software, IoT and edge solutions. This partnership brings together complementary technologies and ecosystems to realize the industrial metaverse. Siemens is uniquely positioned at the intersections of the real and digital world, information technology and operational technology. The Siemens Xcelerator platform connects mechanical, electrical and software domains across the product and production processes and enables the convergence of IT and OT. NVIDIA Omniverse is an AI-enabled, physically simulated and industrial-scale virtual-world engine that enables for the first time full-fidelity live digital twins. NVIDIA AI, used by more than 25,000 companies worldwide, is the world’s most popular AI platform and the intelligence engine of Omniverse in the cloud and autonomous systems at the edge. NVIDIA Omniverse and AI are ideal computation engines to represent the comprehensive digital twin from Siemens Xcelerator. About NVIDIA- Since its founding in 1993, NVIDIA (NASDAQ: NVDA) has been a pioneer in accelerated computing. The company’s invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined computer graphics and ignited the era of modern AI. NVIDIA is now a full-stack computing company with data-center-scale offerings that are reshaping industry. More information at https://nvidianews.nvidia.com/. Siemens AG (Berlin and Munich)- is a technology company focused on industry, infrastructure, transport, and healthcare. From more resource-efficient factories, resilient supply chains, and smarter buildings and grids, to cleaner and more comfortable transportation as well as advanced healthcare, the company creates technology with purpose adding real value for customers. By combining the real and the digital worlds, Siemens empowers its customers to transform their industries and markets, helping them to transform the everyday for billions of people. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a globally leading medical technology provider shaping the future of healthcare. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power.

Read More

Spotlight

Remanufacturing worn-out vehicle components are increasingly important. Around the world, ZF plants like Nottingham in the UK are putting a wide variety of used parts through an industrial remanufacturing process, saving energy and conserving valuable raw materials.

Resources